cerrar
Tagged with Generics

Byung Guk Yang – CEO, Daewoong Bio, South Korea
Dr Byung Guk Yang, CEO of Daewoong Bio, explains the challenges the Korean healthcare system is facing and how his experience in the public sector now…

4+7: China’s New Volume-Based Purchasing Policy
In late 2018 China adopted a novel procurement scheme with the aim of dramatically cutting the amount being paid for generic drugs. The policy’s…

“Restricting Drug Patent Settlements is Bad for US…
Chester “Chip” Davis, Jr, the President and CEO of the Association for Accessible Medicines (AAM) in the US urges Congress to avoid restricting…

Enrique Ordieres – President, Cinfa Group, Spain
Enrique Ordieres, president of Cinfa Group, the leading Spanish generics company, highlights the importance of diversification and…

Adrian van den Hoven – Director General, Medicines for…
Over the last ten years, generic medicines have increased access to medicines by over 100% in 7 key therapeutic areas and have provided massive…

Juan Luis Fernández Balaguer – General Manager,…
Juan Luis Fernández Balaguer, general manager of Laboratorios Combix, the Spanish affiliate of Zydus Cadila, shares the milestones achieved by the…

Funda Gücer – Country Manager, Mylan Turkey
Funda Gücer, country manager at Mylan Turkey, portrays her experience in introducing the company to the Turkish market. She provides her expert…

The Long and Short of Drug Shortages in America
Chester “Chip” Davis, Jr, the President and CEO of the Association for Accessible Medicines (AAM) weighs in on the issue of drug shortages in…

Joachim Teubner – General Manager, Aristo Pharma Iberia,…
Joachim Teubner, general manager of Aristo Pharma Iberia, a generics player, highlights the strategy that has helped the company realize rapid growth…

NEW Special Pharma Report on Malaysia
Click here to download the Healthcare & Life Sciences Review Malaysia 2018. After recent elections conducted in May 2018 saw Mahathir…

Tuğçe Koç – Board Member, Onko Koçsel, Turkey
Tuğçe Koç reveals how Onko Koçsel was able to quickly grow from an in-licenser to a production-oriented pharmaceutical company with an…

David Ho – Managing Director, Hovid, Malaysia
David Ho, managing director of Hovid, introduces the success story of his family-owned company, which started at a Chinese herbal tea manufacturer and…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here